Niva Bupa Q3 FY26 PAT Surges 74% to ₹208 Cr on Strong Premium Growth
Niva Bupa reported a 74% surge in PAT for 9M FY26, reaching ₹208 crore. Q3 FY26 PAT was over ₹76 crore. GWP grew 55% YoY to ₹2,231 crore in Q3 FY26. Retail health market share increased to 10.2%. Customer base grew 23% to 24.5 million lives insured.
The substantial growth in PAT and GWP, coupled with an expanding market share and customer base, indicates a positive and significant impact on the company's financial health and market position.
The company has reported significant year-on-year growth in Profit After Tax (PAT) and Gross Written Premium (GWP), along with an increase in market share and customer base, indicating strong financial and operational performance.
Niva Bupa Health Insurance Company Limited announced its unaudited financial results for the third quarter and nine months ended December 31, 2025. The company reported a Profit After Tax (PAT) of over ₹76 crore for Q3 FY26 and ₹208 crore for the nine-month period ending December 31, 2025.
On a reported basis, Gross Written Premium (GWP) for Q3 FY26 grew by 55% year-on-year to ₹2,231 crore, compared to ₹1,442 crore in Q3 FY25. For the nine months of FY26, GWP stood at ₹5,706 crore, registering a 22% year-on-year growth.
On a like-to-like basis (without the 1/n accounting impact), Q3 FY26 GWP increased by 32% to ₹2,327 crore, and 9M FY26 GWP reached ₹6,309 crore, reflecting a 26% year-on-year growth.
The Combined Insurance Service Ratio (IFRS) for 9MFY26 improved by 0.51 percentage points year-on-year. The Claims Settlement Ratio stood at 94.1% for Q3 FY26 and 94.4% for 9M FY26. Niva Bupa's retail health market share rose by 1.4 percentage points to 10.2% in Q3 FY26. The customer base grew by 23% year-on-year, with the number of lives insured reaching 24.5 million.
Net Promoter Score (NPS) improved to 59 for Q3 FY26, an increase of 3.4 points compared to the same quarter last year. For 9M FY26, NPS stood at 58, reflecting an improvement of 5.4 points over the same period last year.
Krishnan Ramachandran, MD & CEO, Niva Bupa, commented that the Q3 FY26 performance reflects the strength of their growth strategy, increasing relevance in the retail health insurance market, and sustained focus on profitability. He reiterated the commitment to improving customer outcomes while building a resilient and profitable health insurance franchise.
What to do with a filing like this
Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.